Blue Owl Capital Inc. Class A Common Stock (OWL)

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Blue Owl Capital Inc. (“Blue Owl” or “the Company”) (NYSE: OWL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Blue Owl Capital (“Blue Owl” or the “Company”) (NYSE:OWL) securities during the period of February 6, 2025 through November 16, 2025, inclusive (“the Class Period”).

NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Blue Owl Capital Inc. (“Blue Owl” or the “Company”) (NYSE: OWL) between February 6, 2025 through November 16, 2025, inclusive (collectively, the “Class Period”).

Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Blue Owl Capital Inc. (NYSE: OWL) between February 6, 2025 and November 16, 2025. Blue Owl describes itself as an “an asset management firm which specializes in alternative investment solutions, primarily private credit.”

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Blue Owl Capital Inc. (“Blue Owl” or the “Company”) (NYSE: OWL) securities between February 6, 2025 and November 16, 2025, inclusive (the “Class Period”). Blue Owl investors have until February 2, 2026 to file a lead plaintiff motion.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Blue Owl Capital Inc. (“Blue Owl” or the “Company”) (NYSE: OWL) and reminds investors of the February 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, captioned Goldman v. Blue Owl Capital Inc., et al., Case No. 1:25-cv-10047, on behalf of persons and entities that purchased or otherwise acquired Blue Owl Capital Inc. (“Blue Owl” or the “Company”) (NYSE: OWL) securities between February 6, 2025 and November 16, 2025, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

Law Offices of Howard G. Smith announces an investigation on behalf of Blue Owl Capital Inc. (“Blue Owl” or the “Company”) (NYSE: OWL) investors concerning the Company’s possible violations of federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Blue Owl Capital Inc. (“Blue Owl” or the “Company”) (NYSE: OWL) investors concerning the Company’s possible violations of the federal securities laws.

The Law Offices of Frank R. Cruz announces an investigation of Blue Owl Capital Inc. (“Blue Owl” or the “Company”) (NYSE: OWL) on behalf of investors concerning the Company’s possible violations of federal securities laws.

Financing brings total secured from institutional lenders to over $1.5 billion across Alterra’s fully discretionary IOS funds

PALO ALTO, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced it has sold a portion of royalties due to the Company from sales of BEYONTTRA in Europe to HealthCare Royalty (“HCRx”) and funds managed by Blue Owl Capital (“Blue Owl”) for $300 million. This royalty financing agreement monetizes select anticipated royalties and provides immediate less-dilutive capital to the Company.

Annual summit continues to grow as a unique and leading industry event, bringing together key stakeholders and partners to advance women’s leadership in the digital economy

Crusoe Energy Systems LLC (“Crusoe”), a vertically-integrated AI infrastructure company, Blue Owl Capital Inc. (“Blue Owl”), a leading alternative asset manager, and Primary Digital Infrastructure, an advisory and investor firm focused in the data center industry, announced today a $3.4 billion joint-venture to fund purpose-built data center capacity at the previously announced Lancium Clean Campus in Abilene, Texas. Under the terms of the fully funded forward takeout, funds managed by Blue Owl’s Real Estate platform and Primary Digital Infrastructure will jointly sponsor the 206 MW 998,000 square foot data center being designed, built, and operated by Crusoe.

The Dot Group (“Dot” or the “Group”), the transformational leader in global student living, is pleased to announce a strategic financing relationship with Blue Owl’s GP Strategic Capital platform (“Blue Owl”), which provides minority equity and financing solutions to private capital managers.

Low-cost financing capitalizes on XOMA’s $14 million acquisition of VABYSMO® (faricimab) royalties in 2021

Stonepeak, a leading alternative investment firm specializing in infrastructure and real assets, today announced that Blue Owl’s GP Strategic Capital platform (formerly known as Dyal Capital), a leading capital provider for institutional alternative asset managers, has made a passive, minority investment in Stonepeak. Terms of the transaction were not disclosed.